AEOLUS PHARMACEUTICALS, INC. - FORM 10-K - EX-23.1 - CONSENT OF HASKELL & WHITE LLP - December 28, 2009

Attached files

file filename
10-K - FORM 10-K - FISCAL YEAR ENDED SEPTEMBER 30, 2009 - AEOLUS PHARMACEUTICALS, INC.form10k.htm
EX-31.2 - CFO CERTIFICATION - AEOLUS PHARMACEUTICALS, INC.ex312.htm
EX-31.1 - CEO CERTIFICATION - AEOLUS PHARMACEUTICALS, INC.ex311.htm
EX-32.1 - CEO-CFO CERTIFICATION PURSUANT TO 18 U.S.C. 1350 AS ADOPTED PURSUANT TO SECTION 906 - AEOLUS PHARMACEUTICALS, INC.ex321.htm
EX-21.1 - LIST OF SUBSIDIARIES - AEOLUS PHARMACEUTICALS, INC.ex211-subs.htm
 
Exhibit 23.1



CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



We consent to the incorporation by reference in the Registration Statements of Aeolus Pharmaceuticals, Inc. on Form S-8 (File Nos. 333-12923, 333-53017, 333-33636, 333-94169, 333-58754, 333-99421, 333-98635, 333-98637, 333-99421-99, 333-115499, 333-121424, 333-121425 and 333-141633), of our report dated December 28, 2009, appearing in the Annual Report on Form 10-K of Aeolus Pharmaceuticals, Inc. for the year ended September 30, 2009, which includes an explanatory paragraph expressing substantial doubt about the Company’s ability to continue as a going concern.


                                   /s/ Haskell & White LLP

HASKELL & WHITE LLP

Irvine, California
December 28, 2009

Stock widget

Investing forum

AEOLUS PHARMACEUTICALS, INC. Reports